Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Erlotinib | 3.1623 | uM | 7 | 312.50 | 61.21 | 125.00 | 1198.75 | 0.1043 | 0.1810 |
| MCF 10A | Lapatinib | 0.0016596 | uM | 7 | 312.50 | 61.21 | 2071.00 | 1198.75 | 1.7276 | 1.2717 |
| MCF 10A | Linsitinib | 1 | uM | 7 | 312.50 | 61.21 | 380.00 | 1198.75 | 0.3170 | 0.5303 |
| MCF 10A | Lapatinib | 3.1623 | uM | 7 | 312.50 | 61.21 | 929.00 | 1198.75 | 0.7750 | 0.8847 |
| MCF 10A | Linsitinib | 0.0033113 | uM | 7 | 312.50 | 61.21 | 1879.00 | 1198.75 | 1.5675 | 1.2208 |
| MCF 10A | 17-AAG | 0.31623 | uM | 7 | 312.50 | 61.21 | 127.00 | 1198.75 | 0.1059 | 0.1854 |
| MCF 10A | 17-AAG | 0.01 | uM | 7 | 312.50 | 61.21 | 156.00 | 1198.75 | 0.1301 | 0.2436 |
| MCF 10A | Lapatinib | 1 | uM | 7 | 312.50 | 61.21 | 1131.00 | 1198.75 | 0.9435 | 0.9731 |
| MCF 10A | Erlotinib | 0.0033113 | uM | 7 | 312.50 | 61.21 | 1163.00 | 1198.75 | 0.9702 | 0.9859 |
| MCF 10A | Erlotinib | 0.31623 | uM | 7 | 312.50 | 61.21 | 566.00 | 1198.75 | 0.4722 | 0.6792 |
| MCF 10A | Lapatinib | 0.31623 | uM | 7 | 312.50 | 61.21 | 839.00 | 1198.75 | 0.6999 | 0.8404 |
| MCF 10A | Erlotinib | 10 | uM | 7 | 312.50 | 61.21 | 75.00 | 1198.75 | 0.0626 | 0.0485 |
| MCF 10A | Erlotinib | 19.9526 | uM | 7 | 312.50 | 61.21 | 89.00 | 1198.75 | 0.0742 | 0.0911 |
| MCF 10A | 17-AAG | 0.0033113 | uM | 7 | 312.50 | 61.21 | 943.00 | 1198.75 | 0.7867 | 0.8912 |
| MCF 10A | Lapatinib | 10 | uM | 7 | 312.50 | 61.21 | 52.00 | 1198.75 | 0.0434 | -0.0373 |
| MCF 10A | 0 | uM | 7 | 312.50 | 61.21 | 1541.00 | 1198.75 | 1.2855 | 1.1205 | |
| MCF 10A | 0 | uM | 7 | 312.50 | 61.21 | 2.00 | 1198.75 | 0.0017 | -0.5494 | |
| MCF 10A | 0 | uM | 7 | 625.00 | 98.92 | 2.00 | 6877.50 | 0.0003 | -0.4714 | |
| MCF 10A | 0 | uM | 7 | 625.00 | 98.92 | 1060.00 | 6877.50 | 0.1541 | 0.4734 | |
| MCF 10A | Linsitinib | 0.01 | uM | 7 | 625.00 | 98.92 | 1413.00 | 6877.50 | 0.2055 | 0.5443 |
| MCF 10A | Linsitinib | 0.031623 | uM | 7 | 625.00 | 98.92 | 2862.00 | 6877.50 | 0.4161 | 0.7330 |
| MCF 10A | 0 | uM | 7 | 625.00 | 98.92 | 2053.00 | 6877.50 | 0.2985 | 0.6415 | |
| MCF 10A | 17-AAG | 1 | uM | 7 | 625.00 | 98.92 | 72.00 | 6877.50 | 0.0105 | -0.0506 |
| MCF 10A | Linsitinib | 10 | uM | 7 | 625.00 | 98.92 | 190.00 | 6877.50 | 0.0276 | 0.1126 |
| MCF 10A | 17-AAG | 0.1 | uM | 7 | 625.00 | 98.92 | 79.00 | 6877.50 | 0.0115 | -0.0361 |